Showing results (1081-1090 of 1,255) with videos related to
Sort By:
Pageof 126
Cancer Treatment and Research Communications|February 22, 2021
The regulation of cyclin D promoters - reviewJan Pawlonka, Beata Rak, Urszula AmbroziakCancer Treatment and Research Communications|February 13, 2021
Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm changeBeatrice Detti, Gianluca Ingrosso, Carlotta Becherini, et al.Cancer Treatment and Research Communications|February 13, 2021
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patientsMohamad Barakat, Maher Albitar, Robin Whitney, et al.Cancer Treatment and Research Communications|February 5, 2021
Exploring the molecular subclasses and stage-specific genes of oral cancer: A bioinformatics analysisAbdul Raheem Fathima Shafana, Gatamanna Arachchige Isuri Uwanthika, Thangathurai KartheeswaranCancer Treatment and Research Communications|February 5, 2021
Safety and efficacy of trastuzumab emtansine (TDM-1) in a patient on hemodialysis for renal failureA Falcón González, P Estévez Garcia, A Sánchez Gastaldo, et al.Cancer Treatment and Research Communications|February 26, 2019
Diagnostic utility of epigenetics in breast cancer - A reviewShowkat Ahmad Bhat, Sabhiya Majid, Hilal Ahmad Wani, et al.Cancer Treatment and Research Communications|March 3, 2019
De-novo metastatic breast cancers with or without primary tumor resection - A 10-year studyMichael Co, Judy Ng, Ava KwongCancer Treatment and Research Communications|October 23, 2018
Abiraterone in metastatic castration-resistant prostate cancer: Efficacy and safety in unselected patientsGrégoire Marret, Ludovic Doucet, Christophe Hennequin, et al.Cancer Treatment and Research Communications|July 13, 2019
Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancerMamta Parikh, Maria Galkin, Ann Brunson, et al.Cancer Treatment and Research Communications|July 13, 2019
Clinical evaluation of the iXip index to reduce prostate re-biopsiesAndrea Benedetto Galosi, Lucio Dell'Atti, Alessandro Bertaccini, et al.Pageof 126